Treatment of Alzheimer's disease

被引：2
|
作者：
Basun, H
机构：
[1] AstraZeneca R&D, Clin Sci, Sodertalje, Sweden
[2] Univ Uppsala, S-75105 Uppsala, Sweden
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2004年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [21] Advances in the treatment of Alzheimer's disease
    Sloane, PD
    AMERICAN FAMILY PHYSICIAN, 1998, 58 (07) : 1577 - 1586
  • [22] Drug treatment for Alzheimer's disease
    Freyne, A
    Cooney, C
    IRISH MEDICAL JOURNAL, 1999, 92 (07) : 424 - 425
  • [23] Pioglitazone for the treatment of Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (01) : 97 - 101
  • [24] Rivastigmine in the treatment of Alzheimer's disease
    Deleu, D
    EUROPEAN NEUROLOGY, 2001, 46 (02) : 111 - 111
  • [25] Semagacestat for Treatment of Alzheimer's Disease
    Gupta, Veer B.
    Gupta, Vivek K.
    Martins, Ralph
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (17): : 1660 - 1661
  • [26] Nanomedicine for the treatment of Alzheimer's disease
    Gregori, Maria
    Masserini, Massimo
    Mancini, Simona
    NANOMEDICINE, 2015, 10 (07) : 1203 - 1218
  • [27] Nanomedicine for the Treatment of Alzheimer's Disease
    Formicola, Beatrice
    Cox, Alysia
    dal Magro, Roberta
    Masserini, Massimo
    Re, Francesca
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2019, 15 (10) : 1997 - 2024
  • [28] Optimism in the treatment of Alzheimer's disease
    Carrier, L
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1999, 24 (05): : 398 - 401
  • [29] Galantamine in the treatment of Alzheimer's disease
    Latalova, K. L.
    Pidrman, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S476 - S476
  • [30] Advances in the treatment of Alzheimer's disease
    Schneider, LS
    AGING-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 10 (02): : 156 - 157
12345